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Abstract: Background: Increased availability and accessibility of antiretroviral therapy (ART) has improved the length 
and quality of life amongst people living with HIV/AIDS. This has changed the landscape for care from episodic to long-
term care that requires more monitoring of adherence. This has led to increased demand on human resources, a major 
problem for most ART programs. This paper presents experiences and perspectives of providers in ART facilities, 
exploring the organizational factors affecting their capacity to monitor adherence to ARVs. 
Methods: From an earlier survey to test adherence indicators and rank facilities as good, medium or poor adherence 
performances, six facilities were randomly selected, two from each rank. Observations on facility set-up, provider-patient 
interactions and key informant interviews were carried out. The strengths, weaknesses, opportunities and threats identified 
by health workers as facilitators or barriers to their capacity to monitor adherence to ARVs were explored during group 
discussions. 
Results: Findings show that the performance levels of the facilities were characterized by four different organizational 
ART programs operating in Uganda, with apparent lack of integration and coordination at the facilities. Of the six 
facilities studied, the two high adherence performing facilities were Non-Governmental Organization (NGO) programs, 
while facilities with dual organizational programs (Governmental/NGO) performed poorly. Working conditions, record 
keeping and the duality of programs underscored the providers’ capacity to monitor adherence. Overall 70% of the 
observed provider-patient interactions were conducted in environments that ensured privacy of the patient. The mean 
performance for record keeping was 79% and 50% in the high and low performing facilities respectively. Providers often 
found it difficult to monitor adherence due to the conflicting demands from the different organizational ART programs. 
Conclusion: Organizational duality at facilities is a major factor in poor adherence monitoring. The different ART 
programs in Uganda need to be coordinated and integrated into a single well resourced program to improve ART services 
and adherence monitoring. The focus on long-term care of patients on ART requires that the limitations to providers’ 
capacity for monitoring adherence become central during the planning and implementation of ART programs. 
Keywords: HIV/AIDS, antiretroviral therapy, providers, adherence monitoring, Uganda. 
BACKGROUND 
  The rapid scale-up of antiretroviral therapy (ART) in 
sub-Saharan African (SSA) countries has not only increased 
availability and accessibility of these drugs but has also 
improved the length and quality of life amongst people 
living with HIV/AIDS (PLWHA) [1-3]. As patients on ART 
live longer, the landscape for care tends to change from acute 
or episodic care to one that now requires chronic or long-
term care, and careful monitoring of adherence becomes   
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especially important since the level of adherence contributes 
to treatment outcomes [4,5]. For ART programs in SSA, 
monitoring of adherence is one of the most challenging 
activities [6], because of the underlying weaknesses in the 
health infrastructure, increased demand for financial and 
human resources, and especially the apparent decline in 
human resource in the public sector [7-9]. The support of 
adherence monitoring in SSA thus calls for effective and 
efficient coordination of ART programs that have strong 
linkages between policy, organizations and the human 
resource which should reflect the local magnitude and trends 
of HIV/AIDS. 
  Recent reports show that the prevalence of HIV in 
Uganda is on average 5.4% [10], with about 286 facilities in 18    The Open AIDS Journal, 2011, Volume 5  Obua et al. 
both public and private sector providing ART to some 
120,000 patients of the nearly 400,000 who were in need of 
therapy by 2007 [11]. These figures are likely to go upwards 
as the drive is to expand the provision of ARVs to lower 
level health facilities. It is likely that the available human 
resource will face challenges in coping with the burden of 
this expansion, especially to monitor adherence and assure 
the quality of care [12,13]. 
  The scale-up of ART in Uganda and other SSA countries 
has been successful largely because of massive efforts from 
international philanthropists and partners such as the 
GLOBAL FUND for AIDS, TB and Malaria (GFATM), the 
Presidential Emergency Plan for AIDS Relief (PEPFAR) and 
many local players from the public and private sectors. The 
one area that seems to have been inadequately addressed by 
these efforts is human resources [14]. Despite the concerted 
training of more health providers in HIV/AIDS clinical care 
provision, most public organizations have not been able to 
recruit and retain sufficient health workers, thus calling for 
innovations such as task shifting in order to cope with human 
resource demands. Task shifting in clinical care is the 
transfer or delegation of defined responsibilities to other 
providers usually from higher to lower cadres and sometimes 
to non-professionals [15,16]. Uganda is one of the SSA 
countries that has adopted task shifting as a means to 
mitigate deficiencies in human resource in the roll-out of 
ART programs, however task shifting is not without 
challenges for the organization as well as the health 
providers [10]. Experiences and perspectives of providers 
involved in these programs open opportunities to explore 
organizational factors from where new strategies could be 
formed [17], for effective ART adherence monitoring. 
  It is known that low adherence and low retention of 
patients on ARVs are important predictors of poor treatment 
outcomes [18] and the extent to which organizational factors 
are responsible for these are important if interventions are to 
be planned. For the programs, the limited numbers of health 
workers hinder the capacity to monitor the adherence to 
ART, especially where health workers are not involved in 
policy making and only viewed as inputs necessary for 
effective ART programs [19]. From the providers’ view 
point, these challenges can only be better understood when 
their perspectives regarding monitoring of adherence in ART 
programs are explored in the light of their day-to-day 
experiences, such as working in multiple ART programs 
[20]. This paper presents experiences and perspectives of 
providers in ART facilities, exploring the organizational 
factors affecting their capacity to monitor adherence to 
ARVs. 
METHODS 
Study Sites and Study Design 
  This was a cross-sectional determinants study following 
an adherence indicators survey conducted in 20 facilities in 
both rural and urban settings of Uganda to determine the 
facility adherence performances, from which facilities were 
ranked either as high, medium or low adherence performance 
[21]. Three main adherence measures were considered 
before ranking; percentage of days covered by dispensed 
drugs over a 183-day period; average self reported 
adherence; and attendance to next appointment. The rankings 
were then based on overall mean score for all adherence and 
defaulting measures that scored from 1(high), 2(medium) to 
3 (poor). In the original survey, four types of organizational 
systems were found operating in the facilities, distributed as 
shown in Table 1 with facility ranking. The survey showed 
that all facilities with mixed programs had poor adherence 
performance, and all purely Non-Governmental 
Organization/Not-For-Profit Organizations (NGO/NFPO) 
had high adherence performances, while most purely 
government program facilities had better (medium) 
adherence performance than the mixed programs (Table 1). 
  In the current study, six facilities, two from each 
performance level were randomly selected for in-depth study 
of organizational/provider determinants of monitoring 
adherence to ART, including governmental and non-
governmental facilities situated in rural and urban settings of 
the country. After randomization, the high performing 
facilities selected were NGO only programs, the medium 
performing facilities were Government (GOV) only 
programs, and the poor performing facilities had mix 
programs. 
Table 1.  Number of Facilities Distributed on Organizational 
Type and Adherence Performance Ranking from 
ART Facility Survey in Uganda 
 
Adherence Performance Ranking  Facility  
Type/Level 
Organizational  
Type/Program  Low Medium High 
GOV - 2 - 
RRH (n=5) 
Mix   3  -  - 
GOV   2  4  - 
DH (n=7) 
Mix   1  -  - 
NGO (n=5)  NFPO   -  -  5 
PVT (n=2)  FPO   -  1  1 
 Total  6  7  6 
GOV-Government, NGO—nongovernmental,  RRH—Regional Referral Hospital, 
DH—District Hospital, PVT-Private, NFPO-not for profit organization, FPO-for profit 
organization, Mix- GOV/NFPO. 
 
Study Population and Tools 
  Staff and in-charge managers at the selected facilities 
were interviewed. Sit-in observations of providers’ 
interaction with patients aged 18 years or above who were on 
ART for at least six months were selected conveniently as 
they came for care. The data collection tools consisted of in-
charge and staff interview, facility and sit-in observation 
guides. These tools were designed as checklists with the 
focus on identifying strengths and weaknesses that have a 
bearing on adherence within the following areas in the 
facility: organizational structure, staffing, drug supply and 
dispensing, daily work load, laboratory resources and 
integration of services in the clinic. Interviews with in-
charge managers were performed in order to understand the Multiple ART Programs  The Open AIDS Journal, 2011, Volume 5    19 
work procedures and the dynamics of the ART program in 
the facilities. 
  Sit-in observations were performed to observe the 
patient-provider interactions. A checklist was used to gather 
information on record keeping and content of information 
provided to patients; including details of physical 
examination, opportunistic infections (OIs) screening, 
adverse drug reactions (ADR), adherence monitoring and 
prescribing routines. The length of consultation and 
dispensing time were also noted. The sit-in observations 
provided an objective opportunity to observe the interaction 
in the patient-provider encounters, noting length of 
consultation, and if the environment was appropriate, correct 
information was given and whether certain encounter details 
were recorded. For this study, consultation time was defined 
as the duration from the moment the patient sat down for 
interactions with the provider until the patient was dismissed 
by the provider, while the dispensing time was defined as the 
time from when the dispenser called the patient to the 
dispensing window to be instructed and handed over their 
medicines to when the patient leaves the window. 
  In the interviews, semi-structured questionnaires were 
used, including open-ended questions with suggested areas 
for probing. Information from the perspectives of the 
provider on the healthcare system, the role of the patient, 
staff, and community in supporting adherence and beliefs on 
both challenging and enabling factors were addressed. In 
addition, the impact of the healthcare systems and provider 
experiences were explored using strengths, weaknesses, 
opportunities and threats (SWOT) forms, that were used to 
identify each facility’s internal factors (the facility’s 
resources and capabilities) and external factors (circumstan-
ces in which the facility operates) in providing and monito-
ring adherence to ART. 
Ethical Approval 
  Ethical approval for this study was given by the 
Makerere University Faculty of Medicine Research and 
Ethics Committee. Permission to conduct the study was 
granted by the Uganda National Council of Science and 
Technology and the Uganda National AIDS Control 
Program. All health providers in the facilities studied were 
informed of the study and those who were observed gave 
written consent. The patients were informed and gave group 
verbal consent for the observations of the interactions. 
Data Collection and Analysis 
  In each facility, during the first day, SWOT forms were 
given to all staff by members of the study team. Providers 
were asked to identify the strengths, weaknesses, 
opportunities and threats to high quality service regarding 
ART adherence in their facility and note their reflections in 
the SWOT forms and return them to the team on the next 
day. This was then followed by SWOT group discussion 
with 6 – 8 staff members. The team leader presented an 
overview of the facility findings, the sit-in observations, and 
a summary of the SWOT materials filled in by staff. A 
discussion followed on the factors affecting monitoring of 
adherence at the facilities, including the possible and feasible 
interventions or other remedial actions to overcome 
deficiencies in adherence performance. At all facilities, 
interviews and SWOT discussions were conducted in 
English and were audio recorded. The analysis of the 
qualitative data followed an inductive approach. Audio 
recordings were transcribed verbatim. These were then read 
thoroughly and minutely to allow conceptual clusters of 
ideas and patterns to emerge, which were manually 
organized into descriptive content areas with sublevels. For 
quantitative data, descriptive analysis was performed using 
SPSS version 12, and the results presented as frequencies or 
tabulated. 
RESULTS 
Sit-In Observations of Patient-Provider Interactions 
  A total of 96 provider-patient interactions were observed, 
ranging from 14 to 21 per facility. Staff numbers were higher 
in the higher performing facilities than in the lower facilities, 
while the number of patients attending on a clinic day ranged 
from 31 to 267 (Table 2). The providers included doctors, 
clinical officers and nurses among the prescribing team with 
higher staff to patient ratios in the higher performing 
facilities than in the lower performing ones. More than 2/3 
(70%) of the patient-provider interactions were conducted in 
environments that ensured patient privacy within the 
facilities. The high performing facilities had better 
consultation environment compared to the low performing 
facilities. Most (76%) encounters lasted on average under 10 
minutes, with 19% between 10 – 15 minutes, and only 5% 
lasting more than 15 minutes. There was a significant 
difference in mean consultation time between the high and 
the lower performing facilities (8.2±2.7 vs 6.4±2.4, t-test 
p=0.001 at 95% CI 0.7 – 2.8). Most facilities had similar 
dispensing time except for one of the high adherence 
facilities that had nearly double length of dispensing time 
(Table  2), however comparison of the overall mean 
dispensing time between the high and lower performing 
facilities (66.0±24.6 vs 31.2±8.6) were significant (t-test 
p<0.001 at 95% CI 39.5 – 49.0). 
Information Provision to Patients 
  Overall most encounters showed insufficiencies in the 
information given to the patients about HIV and ART 
regarding the importance of adherence, secondary prevention 
and about adverse drug reactions (ADRs) and OIs. It was 
further observed that provision of information in the areas 
studied was not clearly associated with facility performance 
in terms of ART adherence as the poor performance clinics 
provided information more often than the high performing 
clinics (Table 3). 
Interviews and Group Discussions 
  From the analysis of the interviews and SWOT 
discussions, three main themes emerged related to the impact 
of healthcare systems on the capacity of providers to monitor 
adherence to ARVs The first theme describes providers’ 
unstable working conditions; the second theme adresses the 
important role of records keeping in adherence monitoring 20    The Open AIDS Journal, 2011, Volume 5  Obua et al. 
and the third theme describes providers’ perspectives on the 
quality of the health systems and duality of ART programs. 
Organizational Systems and Working Conditions 
  Generally there were inadequate and/or unstable staffing 
situations in the facilities studied. In the case of high 
performing facilities this was due to the high turnover of 
staff and inability to retain them even though the facilities 
are able to recruit more staff. In the case of lower performing 
facilities, this was often due to a lack of dedicated staff for 
the ART clinics, as the clinics shared staff with other non-
ART provision units. There were prolonged waiting times, 
patient congestion, and an inability to carry out activities and 
record parameters necessary to monitor adherence. In 
facilities where more than one system was managing ARV 
provision (government and NGO) it was found that the 
provider often encountered difficulties in fulfilling the 
obligations of the different systems, such as the different 
formats of records required, ARV enrolment criteria, 
splitting patients in the different program regimens, and the 
different follow-up or patient tracking systems. Although 
facilities were open for as few as one day a week (in the low 
performing facilities) to five days a week (in the high 
performing facilities) as shown in Table 3, it is difficult to 
test any correlation between the opening days with the 
adherence performance of the facilities due to the few 
number of facilities in the study. 
  At facility level some of the major program challenges to 
effective adherence monitoring included: 
Table 2.  Facility Observation on Staff, Provider-Patient Interactions and Other Functionality Parameters 
 
High Adherence  Medium Adherence  Low Adherence  Observed Characteristics 
Facility1 
(NGO) 
Facility2 
(NGO) 
Facility 1 
(GOV) 
Facility2 
(GOV) 
Facility1 
(Mix)  
Facility2 
(Mix) 
Doctors 6  1  1  0  0  2 
Clinic Officer  0  1  1  1  3  1 
Nurses 9  2  1  1  1  5 
Counsellors/community 21  4  2  0  1  0 
Pharmacist/Technicians 3  3  0  0  0  4 
Data Clerks  2  1  0  0  0  1 
Staffing Situation 
Total staff at clinic  41  12  5  2  5  13 
Number of patients attending per visit day   201  32  102  31  267  249 
Staff per patient visit   0.20  0.37  0.05  0.06  0.02  0.05 
Number of Provider-patient interactions observed  15  19  16  16  15  15 
Consultation time (average in minutes)  8  9  6  5  6  7 
Dispensing time (average in seconds)
a  41 90 25 30 25  45 
Laboratory functionality  Full   Full   Partial Partial Partial  Partial 
Number of opening days per week  5  5  1  1  3  5 
aDispenser-patient interaction time from when the patient is called to the dispensing counter to receive medicines to the time he leaves the counter. 
 
Table 3.  Information Provided to Revisiting Patients from Sit-In Observations 
 
Number (%) of Consultations by Facility Ranking 
Type of Information Provided  Overall 
n=96 
High 
n=34 
Medium 
n=32 
Low 
n=30 
General HIV information  4 (4)  1 (3)  0 (0)  3 (10) 
Information on specific ART  5 (5)  1 (3)  0 (0)  5 (17) 
Information on importance of adherence  28 (29)  15 (44)  5 (16)  8 (27) 
Information on secondary prevention  27 (28)  13 (38)  7 (22)  7 (23) 
Information about the prescribed drugs  9 (9)  3 (9)  0 (0)  6 (20) 
Enquiry about adverse drug reactions  21 (22)  7 (21)  5 (16)  9 (30) 
Enquiry about opportunistic infections
a  58 (60)  29 (85)  18 (56)  11 (37) 
aOpportunistic infections such as pnuemocystis carinii pneumonia and cryptoccocal meningitis. Multiple ART Programs  The Open AIDS Journal, 2011, Volume 5    21 
•  Poor/lack of laboratory service, especially the 
inability to perform CD4 tests was seen as a major 
hindrance to effective monitoring of adherence. 
•  Lack of OI drugs – frequent stock-outs of OI drugs 
increases the cost of adherence as patients are forced 
return to the clinics many times. 
•  Few staff and heavy patient load, inadequate 
remuneration and high staff turnover all negatively 
influence the quality services including adherence 
counselling and monitoring. 
  All facilities were severely understaffed and the attrition 
rate was particularly high among doctors, where flexibility in 
function, rotation of staff between different departments, and 
task shifting was used as the main tool to bridge the human 
resource gaps in the facilities. 
Given the limited numbers of doctors, many of 
our nurses here are prescribing medicines and 
they are doing it very well [In-charge manager, 
NGO]. 
  However, task shifting often constrained the already 
overworked providers and, together with negative 
perceptions of the ART unit, providers were often unwilling 
to fulfil the tasks they had been assigned. The availability of 
providers to meet patients’ demands was however critical. 
Providers were seriously concerned about the current patient 
load and the increase in the number of patients, which could 
not be stopped, while the number of health care providers 
remained the same or even decreased affecting their ability 
to monitor adherence. 
…because of the workload when it gets to 
around 2:00 pm people who started by singing 
adherence in a vibrant manner start losing 
interest to talk about the same because they 
are already worn out; and in the long run we 
lose the touch of adherence. [In-charge 
manager, GOV/NGO]. 
  Furthermore, the role of providers went beyond 
providing medications only. Providers also acted as 
educators and trainers of professional counsellors, peer 
counsellors, community based volunteers and the general 
public. They however decried their own lack of training in 
adherence monitoring. 
We have never gone for the training and we 
don’t know whether what we are doing is right 
[Clinical officer, GOV]. 
  The flipside of training providers in adherence support 
was that they became more “marketable” for other more 
financially attractive organizations to employ them, referred 
to as “internal brain-drain”. 
…..there is a problem that the attrition rate, is 
too high especially when it comes to clinicians. 
We send them for further training. So after 
training of course they become more 
marketable and of course there are many 
organisations that are ready to employ them 
[In-charge manager, NGO]. 
Record Keeping as an Important Issue in Adherence 
Monitoring 
  A well-organized record keeping system distinguished 
the higher from the lower performing facilities. It was 
observed that high performing facilities had well organized 
patient tracking and record systems, often with trained 
records assistants in place. During patient-provider 
interactions, providers in high performing facilities recorded 
the date of the visit, the date of next the visit, the drugs and 
the number of medication days prescribed more frequently 
compared to the low performing. The mean performance for 
recording was significantly better in the high performing 
(78.7±39.1%) compared to the low performing facilities 
(50.3±42.4%) with t-test for equality of means giving 
p=0.01at 95%CI of 6.89 – 50.05. Information regarding the 
patients’ current symptoms, laboratory examination results, 
physical examinations and results of clinical examinations 
were often not recorded in lower performing facilities. Only 
having an attendance record, often taken by volunteers, did 
not indicate what the person had come to do at the clinic. 
…but you see, when you have semi-skilled 
manpower you have to talk over this issue 
(records keeping) with a lot of push ………. So 
by that I say that the semi-skilled people 
(volunteers) sometimes don’t know the 
importance of what you wanted. Yet if you 
talked to somebody who understands what 
data implies it would certainly be easy [In-
charge manager, GOV/NGO]. 
  In all facilities the tool frequently used to capture patient 
record was the “blue card”, the patients’ ART 
comprehensive care card, considered to capture most data 
important for care and adherence monitoring. In lower 
performing facilities missing records were often noticed. In 
facilities with dual programs, proper record keeping was 
poor due to the complexity of the different record systems 
that the providers had to cope with, and this was further 
compounded by provider shortage. 
Because of the poor staffing, poor recording 
goes on…. to explain why at times certain 
things go on, because you are the same person 
doing this and doing the other, some things 
may skip your mind [In-charge manager, 
GOV/NGO]. 
Providers’ Perspectives on the Organisation and Duality of 
ART Programs 
  The interviews and discussions paint a picture of many 
serious constraints, sometimes made worse by the fact that 
multiple programs ran concurrently. The providers believed 
there was no integration or coordination of the various 
programs they implemented in the facilities. Even the drugs 
were differently sourced. Running parallel NGO/NFPO and 
Government funded programs within the same facilities 
presented system conflicts. These dual programs proved 
disadvantageous to providers and often portraying providers 22    The Open AIDS Journal, 2011, Volume 5  Obua et al. 
negatively in the eyes of patients as providers have to select 
patients to fit into the different programs. 
  Of all the barriers identified by the providers, drug 
shortages and stock outs were the most frustrating. Providers 
advised their patients to take medications daily for life 
without missing out on doses but when patients came to 
collect their medication there may be none to offer. The 
situation is more complex where drugs are available for one 
program (NGO) and lacking for the other program (GOV) in 
a facility with dual programs. Failure to provide medications 
due to stock out greatly complicated adherence monitoring. 
Sometimes, we have drug stock outs. This is a 
big problem and a big challenge affecting the 
clinic. We tell the patients that once you begin 
on drugs you take them for life yet they come 
and we tell them that we have no drugs. This is 
to them almost sending them to go and die. We 
don’t know what to do… [Clinical officer, 
GOV]. 
  Recurring shortages of ARVs and OI drugs often lead to 
borrowing/lending of drugs, substitution of regimens, and 
sometimes giving drugs for shorter intervals, say for 2 
weeks, even to “stable” patients who normally would have 
returned to the clinic after one month or longer. In the 
facilities with dual programs, providers explained that the 
reasons for the short supplies were partly due to the donors’ 
restrictions on the number of patients to treat and yet more 
patients may qualify for therapy in the Gov program. The 
other reasons were usually miscommunication and 
bottlenecks in supply logistic as drugs were distributed from 
several different donors and procurement chains. 
…we used to make requisition but then we 
found there were no drugs in stock. I think 
there was a problem somewhere. The other 
time they (Ministry of Health) said the drugs 
have come but they had not yet. Something had 
not been done so they could not give them to 
us. ..like there was a logistic problem 
somewhere [In-charge Manager, GOV]. 
Laboratories in Adherence Monitoring 
  Providers viewed the functionality of laboratories as 
important to proper adherence monitoring within the 
programs. While facilities had laboratory technicians, these 
were trained only on how to use the equipments but not on 
maintenance or servicing. The facilities most often did not 
know whom to report laboratory difficulties to, and 
confusion regarding the responsibility for the services was 
evident. None the six facilities performed viral load tests, 
while CD4 testing were only performed in NGO/NFPO 
facilities, and in mixed facilities this was only offered to 
patients enrolled on the NGO programs, making the services 
and monitoring adherence at these facilities inadequate. 
Providers at all government facilities had to rely on their 
clinical assessment in the initiation of therapy and adherence 
monitoring. 
The lab ….can’t do for me the viral load, 
which we are interested in, they can’t do for 
me a CD4 count, I mean these electronic tests. 
There are things like the renal function test 
and liver function test. Those ones I just forget 
about them. Blood chemistry cannot be done, 
yeah, which is very important. ..we can’t do it. 
So we ask for a hand from somewhere else [In-
charge manager, GOV/NGO]. 
DISCUSSION 
  In exploring the functionality of organizational systems 
in ART facilities and the perspectives of health workers 
regarding adherence monitoring in ART programs in 
Uganda, it emerged that both internal and external factors 
were responsible for the level of adherence monitoring. The 
organizational systems operating in various facilities majorly 
contributed to these factors. In monitoring of adherence, the 
high performing facilities were all found to be purely 
NGO/NFPO, while the purely GOV programs had medium 
performance and the poor performing facilities had mixed 
(dual) GOV/NGO programs. This indicated that whenever 
there was a mix in the organizational systems at the 
facilities, adherence performances were not optimal. The 
entry of NGO programs into HIV/AIDS care and service 
improved access to ARVs low income countries such as 
Uganda. A study that looked at the coordination of health 
sector aid in Zambia showed that while aid support to 
HIV/AIDS increased, integration of partners at delivery 
points was lacking [22]. The health workers are then 
presented with difficulties in carrying out routine activities 
such as having to make decisions on which patients to recruit 
in a program, how to keep dual record systems, let alone 
monitor the patients as often staffing levels do not change 
[13]. 
  Where there was duality of programs at a facility, it was 
found that the capacity of health providers to perform 
optimally was adversely affected. This was associated with 
poor rankings of such facilities. The multiplicity of 
requirements in the dual programs challenges the providers 
with the dilemma of fulfilling the competing demands. 
While the NGO programs may have been introduced at the 
GOV facilities to support the government efforts in scaling 
up the delivery of ARVs, it is possible that the provider 
capacity to handle the dual programs may not have been 
taken into account [19]. Secondly the lack of coordination 
and systematic integration at delivery points has also proved 
to be an important weakness in these mixed programs [22]. 
A study that compared three different delivery systems at 
facility level in Uganda also found that lack of collaboration 
between the systems was the main challenge to effective 
ART delivery in the programs [20]. In the present study, 
providers generally found it difficult to perform the different 
tasks simultaneously, and at times this was simply 
impossible. It is therefore imperative that the dual programs 
undergo complete integration so that they are presented at 
the facilities as one program, making it easy for the few staff 
at the facilities to deliver services such as giving longer 
consultation time, providing better information, counselling 
and record keeping, which are key components for adherence 
monitoring [23]. Multiple ART Programs  The Open AIDS Journal, 2011, Volume 5    23 
  Health providers are important partners in the health 
systems or organizations [19]. As such, their perspectives on 
what is important in the implementation of the programs at 
the facility level should be understood and addressed. Each 
provider can only do so much at a time, hence even when 
they are expected to diversify roles during task shifting the 
attendant limitations should be recognized. To ensure quality 
services, a systematic and well targeted approach to task 
shifting is a requirement [15]. In this study, task shifting was 
found to be spontaneous in response to the lack of clinic 
dedicated staff, as this only served to bridge the immediate 
man-power gaps, hence performance did not necessarily 
improve. This is perhaps why GOV and the mixed program 
facilities in the present study were found to have performed 
less than optimally despite the task shifting [12,13]. 
  Staff training is important for performance improvement, 
but numbers are also important. Providers indicated that 
while they would like specific training, more staff should be 
employed and these should be dedicated to ART clinics. 
Where this occurred, especially in NGO program facilities, 
performance in adherence monitoring was often better. In 
most GOV and Mixed programs, lack of trained dedicated 
ART clinic staff and inability to adequately interact with 
patients was perceived as contributing to their incapacity to 
monitor adherence optimally. Similarly, in a meta-analysis 
that compared adherence to ART in SSA and North 
America, it was found that monitoring adherence was 
inadequate due to multiple program factors especially poor 
provider interaction with patients [24]. 
  While adherence to ART is often the responsibility of the 
patient [25], the role of providers in ensuring this often goes 
beyond providing medications only. In the present study, 
providers performed other functions including being 
educators to patients and other staff. If monitoring of 
adherence is to be carried out optimally, program planning 
must therefore include provision for adequate staff 
recruitment, retraining and retention. In this study, providers 
agreed that their performance in monitoring adherence was 
often poor because the health system planners appeared not 
to have taken into account the need to recruit and retain staff 
at the facilities. The frequent internal brain drain occurs due 
to the fact the there is a proliferation of NGO programs 
which all require trained staff. These compete by hiking 
remunerations to attract the already trained staff from other 
programs. The apparent brain drain is not without some 
positive effects, as at the wider health systems level it helps 
to retain trained health workers within the health system in 
the country [26], as opposed to the external brain drain that 
has destabilized the SSA health systems. If NGO ART 
programs were integrated into the GOV programs there 
would be more stability in staffing and minimal staff turn-
over. While the many ART programs may improve the 
number of patients with access to ARVs, there is usually no 
proportional increase in health workers, and failure to take 
into account what it would take to monitor adherence to the 
medications in the long run is a disservice to the patients 
[27]. 
  In this study it was observed that diagnosis and follow-up 
of patient progress is mainly based on clinical assessment. 
While this is a useful for diagnosis and assessment for 
initiation of therapy, most typical clinical features change 
once patients have been on therapy for some period. This 
makes clinical assessment unreliable for monitoring of 
adherence. The present study showed that facilities with 
lower adherence monitoring did not routinely use other 
assessment methods, such as CD4 tests, to monitor 
adherence and inability to perform laboratory tests in 
monitoring ART is a frequent limitation in most SSA ART 
program [28]. 
  Providers often feel wrongly vilified for external system 
problems over which they have no control, such as drug and 
staff shortages, non-functional laboratories, and parallel 
programs which seem to bring discontent among the patient 
communities. Having to turn patients back due to lack of 
drugs is as painful to the providers as it is to the patients and 
so, they feel deflated and discouraged, hence the desire to 
seek for transfer to better performing organizations. The 
number of providers required for optimal services and 
adherence monitoring is projected to double yearly for the 
next decade [29]. This is a real dilemma that threatens the 
successes in scale-up of ART programs [30]. In this study 
the single program facilities had a four to ten times better 
staffing ratio, with better adherence monitoring, further 
emphasizing the need for optimizing the number of providers 
at the facilities. 
  However whether providers are completely free of blame 
for systems failures or whether reorganization of programs 
by centrally coordinating them into a single integrated 
program will indeed improve services and adherence 
monitoring are issues that will require a wider study that 
should involve policy level down to the facilities, the 
providers inclusive. 
CONCLUSIONS 
  Organizational duality at facilities is a major factor in 
poor adherence monitoring. The different ART programs in 
Uganda need to be coordinated and integrated into a single 
well resourced program to improved ART services and 
adherence monitoring. The focus on long-term care of 
patients on ART requires that the limitations to provider 
capacity for monitoring adherence become central during the 
planning and implementation of ART programs. 
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